Stocks-SWTX-SpringWorks Therapeutics Inc

SWTX SpringWorks Therapeutics Inc

49.07 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: SpringWorks Therapeutics Inc's revenues decreased by NaN and amounted to 0.00. Net income decreased by 59.52% to -277.42M. Net assets decreased by NaN to 558.19M and EPS decreased from N/A to -5.21.
SWTX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
-32.55%
Operating Margin
N/A
Return On Investment
-29.18%